The Application segment of the Selenium-enriched Yeast market is delineated by end‑use categories that drive demand differentially. Animal feed accounts for the largest share, leveraging selenium’s role in livestock health, immune function, and growth performance; this sub‑segment typically represents 45 % of total revenue. Human nutrition follows, where the yeast is incorporated into dietary supplements and functional foods to address selenium deficiencies, contributing approximately 30 % of market size. The Pharmaceutical application, focused on clinical formulations such as selenium‑based antioxidants and therapeutic agents, comprises roughly 15 % of the market, reflecting higher unit values but lower volume. Finally, the Agricultural niche, including bio‑fertilizers and soil conditioners enriched with selenium, holds an estimated 10 % share. Collectively, these application categories constitute the core of Selenium-enriched Yeast segmentation, each influencing overall market dynamics through distinct regulatory pathways, pricing structures, and adoption rates.